Veracyte (VCYT) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $0.01.
- Veracyte's Debt to Equity rose 7169.82% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year increase of 7169.82%. This contributed to the annual value of $0.01 for FY2024, which is 46743.99% up from last year.
- As of Q3 2025, Veracyte's Debt to Equity stood at $0.01, which was up 7169.82% from $0.01 recorded in Q2 2025.
- In the past 5 years, Veracyte's Debt to Equity registered a high of $0.01 during Q4 2024, and its lowest value of $0.0 during Q3 2023.
- Its 5-year average for Debt to Equity is $0.01, with a median of $0.01 in 2022.
- Its Debt to Equity has fluctuated over the past 5 years, first plummeted by 6456.97% in 2022, then soared by 46743.99% in 2024.
- Veracyte's Debt to Equity (Quarter) stood at $0.0 in 2021, then skyrocketed by 130.43% to $0.01 in 2022, then crashed by 54.85% to $0.0 in 2023, then surged by 467.44% to $0.01 in 2024, then decreased by 25.27% to $0.01 in 2025.
- Its Debt to Equity stands at $0.01 for Q3 2025, versus $0.01 for Q2 2025 and $0.01 for Q1 2025.